SCHEMBL13330619

SCHEMBL13330619

CC(C)(c1ccccc1)C(C)(C)c1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
BLM P54132 3/20 0.41
CYP2D6 P10635 1/20 0.41
KDM4E B2RXH2 3/20 0.40
CHRM3 P20309 1/20 0.39
ALOX15 P16050 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC22A2 O15244 1/20 0.38
SLC22A1 O15245 1/20 0.38
PGR P06401 1/20 0.38
THRB P10828 1/20 0.38
ADRB3 P13945 1/20 0.38
OPRK1 P41145 1/20 0.38
PMP22 Q01453 1/20 0.38
KCNH2 Q12809 1/20 0.38
PDE3A Q14432 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18595142 0.83 CYP19A1 (0.45) CHRM2SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL19592701 0.81 SMN1; SMN2 (0.42) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL7894827 0.81 SMN1; SMN2 (0.50) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL2694787 0.81 CHRM2 (0.54) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL85361 0.80 SMN1; SMN2 (0.54) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL23918901 0.79 CHRM2 (0.45) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL7559746 0.78 SMN1; SMN2 (0.57) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL4379933 0.78 CHRM2 (0.47) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL23619158 0.78 SMN1; SMN2 (0.57) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6
SCHEMBL31143640 0.78 SMN1; SMN2 (0.57) CHRM2SMN1; SMN2L3MBTL1BLMCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100121065-A1 Phosphors with High Luminous Efficiency and Display Device Containing Them GRACEL DISPLAY INC. (KR) 2010-05-13 US disclosed
US-20100121065-A1 Phosphors with High Luminous Efficiency and Display Device Containing Them GRACEL DISPLAY INC. (KR) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100121065-A1 Phosphors with High Luminous Efficiency and Display Device Containing Them PPIP5K2, ACP1, INPP5B CHRM2 4214/4885SMN1; SMN2 4377/4885L3MBTL1 2392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.